Live search
TopFind is fetching the latest matches for your search.
We reviewed 40 live results for monoclonal antibodies and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Monoclonal Antibodies and Oncology.
Sumber: AstraZeneca Malaysia
Deskripsi
Soliris (Eculizumab) is a specialized monoclonal antibody and complement inhibitor provided as a 10mg/ml concentrate for infusion to treat rare immune-mediated diseases.
Paling cocok untuk
complement inhibition, rare immune diseases and infusion therapy
Penilaian
Sumber: AstraZeneca Malaysia
Deskripsi
Fasenra (Benralizumab) is an immunomodulatory biologic available in a 30mg pre-filled pen, typically used for severe eosinophilic asthma.
Paling cocok untuk
severe asthma, eosinophilic conditions and monoclonal antibody therapy
Penilaian
Sumber: Pfizer Philippines Inc.
Deskripsi
Trazimera is a monoclonal antibody biosimilar for the treatment of HER2-positive breast and stomach cancers, receiving PH FDA approval in 2022.
Paling cocok untuk
HER2-positive breast cancer, stomach cancer and targeted oncology therapy
Penilaian
| Bandingkan | Soliris | Fasenra | Trazimera (Trastuzumab) |
|---|---|---|---|
| Sumber | AstraZeneca Malaysia | AstraZeneca Malaysia | Pfizer Philippines Inc. |
| Deskripsi | Soliris (Eculizumab) is a specialized monoclonal antibody and complement inhibitor provided as a 10mg/ml concentrate for infusion to treat rare immune-mediated diseases. | Fasenra (Benralizumab) is an immunomodulatory biologic available in a 30mg pre-filled pen, typically used for severe eosinophilic asthma. | Trazimera is a monoclonal antibody biosimilar for the treatment of HER2-positive breast and stomach cancers, receiving PH FDA approval in 2022. |
| Paling cocok untuk | complement inhibition, rare immune diseases and infusion therapy | severe asthma, eosinophilic conditions and monoclonal antibody therapy | HER2-positive breast cancer, stomach cancer and targeted oncology therapy |
| Tag | |||
| Aksi | Lihat detail | Lihat detail | Lihat detail |
| Penilaian |
Jika Anda ingin memulai dari opsi yang paling seimbang, saya merekomendasikan:
"Soliris from AstraZeneca Malaysia."
Saya memilih ini karena High-potency specialized therapy for rare conditions requiring complement system modulation.